Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Nonoxynol-9
DRUG
4 trials
Sponsors
National Institute of Allergy and Infectious Diseases (NIAID)
, Johns Hopkins University
, CONRAD
Conditions
HIV Infections
Vaginal Infections
Vaginal Inflammation
Early Phase 1
A Pilot Study for Toxicity Evaluation of HIV Rectal Microbicides
Completed
NCT00389311
Johns Hopkins University
HIV Infections
Start: 2007-04-30
End: 2009-06-30
Updated: 2015-04-01
Phase 1
A Study of the Effects of Advantage 24 on the Rectum
Completed
NCT00000929
National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections
End: 1999-07-31
Target: 70
Updated: 2021-10-29
Phase 2
Identification of Novel Biomarkers of Cervicovaginal Mucosal Inflammation
Completed
NCT01593124
CONRAD
Vaginal Infections, Vaginal Inflammation
Start: 2012-05-31
End: 2013-04-30
Updated: 2015-03-31
Phase 3
A Study of Nonoxynol-9 (N-9) and HIV Infection
Completed
NCT00000926
National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections
End: 2001-02-28
Target: 4400
Updated: 2021-10-29
Related Papers
Quantitative assessment of altered rectal mucosal permeability due to rectally applied nonoxynol-9, biopsy, and simulated intercourse.
2013-01-16
7 citations